¥ 2978
Key Takeaways
Risk factor
Low price volatility
Profitability factor
Greatly undervalued vs peers
About
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD
Target Price
The average target price of 4553.T is 3921 and suggests 34% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
